Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens.

about

Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens.

Item

http://www.wikidata.org/entity/Q49200882

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Changes in renal function indi ...... ofosbuvir-containing regimens.

@en

Changes in renal function indi ...... ofosbuvir-containing regimens.

@nl

type

Item

label

Changes in renal function indi ...... ofosbuvir-containing regimens.

@en

Changes in renal function indi ...... ofosbuvir-containing regimens.

@nl

prefLabel

Changes in renal function indi ...... ofosbuvir-containing regimens.

@en

Changes in renal function indi ...... ofosbuvir-containing regimens.

@nl

P1476

Changes in renal function indi ...... ofosbuvir-containing regimens.

@en

P2093

Chihong Wu

http://www.w3.org/2001/XMLSchema#string

Dan Liu

http://www.w3.org/2001/XMLSchema#string

Hao Luo

http://www.w3.org/2001/XMLSchema#string

Hongli Xi

http://www.w3.org/2001/XMLSchema#string

Jianhong Chen

http://www.w3.org/2001/XMLSchema#string

Min Yu

http://www.w3.org/2001/XMLSchema#string

Xiaoyuan Xu

http://www.w3.org/2001/XMLSchema#string

Xiaxia Zhang

http://www.w3.org/2001/XMLSchema#string

Yaoyu An

http://www.w3.org/2001/XMLSchema#string

Yihang Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Different interaction profiles of direct-acting anti-hepatitis C virus agents with human organic anion transporting polypeptides

Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment

Drug-drug interactions during antiviral therapy for chronic hepatitis C

Global epidemiology and genotype distribution of the hepatitis C virus infection

Anti-hepatitis C virus drugs and kidney

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential.

P304

90916-90924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18701

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207613

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

sofosbuvir

P932

5710894

http://www.w3.org/2001/XMLSchema#string